GE Healthcare Life Sciences Email Format
Biotechnology ResearchEngland, United Kingdom5001-10000 Employees
GE Healthcare Life Sciences, based in Little Chalfont, England, operates in the biotechnology research sector. It serves life science researchers and biopharmaceutical manufacturers by supporting discovery, development, and application of new therapies and precision medicines. The aim is to enable the right treatment for the right patient in a cost-effective, efficient, and safe way, contributing to improved quality of life. The company organizes its offerings around bioprocess, cell and gene therapy, and genomics and cellular research, drawing on its heritage in biotechnology manufacturing and its infrastructure and service capabilities to help customers build global biomanufacturing capacity where disease demographics create demand. Its customers include academia, biotech, and pharmaceutical companies seeking to accelerate research and scale production. In October 2020, GE Healthcare Life Sciences announced the KUBio box, a fully integrated, adaptable biomanufacturing setting designed to speed the production of viral vector-based gene therapies.